MetaCap

Clinuvel Pharmaceuticals (CUVL) vs Ferguson Enterprises (FERG)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Ferguson Enterprises (FERG) has outperformed Clinuvel Pharmaceuticals (CUVL) over the past year, losing 7.7% versus a loss of 31.6%. Over five years, FERG leads with a +48.7% price change compared with -81.6% for CUVL. Ferguson Enterprises is the larger company by market cap ($42.57 billion vs $282.2 million), about 150.8 times the size.

On valuation, Clinuvel Pharmaceuticals trades at a lower trailing P/E (12.4x vs 21.7x for Ferguson Enterprises). Ferguson Enterprises offers the higher dividend yield (1.93% vs 0.89%).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CUVL-31.62%FERG-7.73%
+16%-9%-34%
Oct 8, 20251 yearOct 8, 2026
CUVL-80.94%FERG+52.20%
+94%+2%-89%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CUVL versus FERG key metrics
MetricCUVLFERG
Share price$5.59$220.04
Market cap$282.22M$42.57B
1-day change-0.18%+1.53%
YTD return-33.96%-2.65%
1-year return-31.62%-7.73%
5-year return-81.60%+48.66%
P/E ratio (TTM)12.4221.66
Forward P/E—17.32
EPS (TTM)$0.45$10.16
Dividend yield0.89%1.93%
Annual dividend$0.05$4.25
Revenue (latest FY)—$30.76B
Revenue growth (YoY)—+3.80%
Net income (latest FY)—$1.86B
Gross margin—30.67%
Operating margin—8.47%
Net margin—6.03%
52-week high$8.92$271.64
52-week low$5.53$212.13
Distance from 52-week high-37.33%-19.00%
Analyst consensus—buy
Avg. price target upside—+29.29%
Average volume13.01K2.32M
Shares outstanding50.49M193.45M
Employees—35,000
SectorMiscellaneousMiscellaneous
IndustryMiscellaneousMiscellaneous

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Ferguson Enterprises is about 150.8 times larger than Clinuvel Pharmaceuticals by market value ($42.57B vs $282.22M).
  • FERG has outperformed CUVL by 23.9 percentage points over the past year.
  • Ferguson Enterprises trades at a higher earnings multiple (21.7x vs 12.4x trailing P/E).
  • Ferguson Enterprises offers a meaningfully higher dividend yield (1.93% vs 0.89%).

About Clinuvel Pharmaceuticals

CUVL stock →

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).

Miscellaneous · Miscellaneous

About Ferguson Enterprises

FERG stock →

Ferguson Enterprises Inc. distributes essential water and air solutions to specialized professional in the United States and Canada.

Miscellaneous · Miscellaneous · 35,000 employees

CUVL vs FERG FAQ

Which is bigger, Clinuvel Pharmaceuticals or Ferguson Enterprises?

Ferguson Enterprises (FERG) is larger, with a market capitalization of $42.57B compared with $282.22M for Clinuvel Pharmaceuticals (CUVL).

Which stock has performed better over the past year, CUVL or FERG?

FERG returned -7.73% over the past 12 months, compared with -31.62% for CUVL (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, CUVL or FERG?

CUVL has the lower trailing P/E at 12.4, versus 21.7 for FERG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Clinuvel Pharmaceuticals or Ferguson Enterprises?

Ferguson Enterprises has the higher yield at 1.93%, compared with 0.89% for Clinuvel Pharmaceuticals.

Are Clinuvel Pharmaceuticals and Ferguson Enterprises in the same industry?

Yes. Both are classified in the Miscellaneous industry within the Miscellaneous sector.

More comparisons